Ligamentum flavum fibrosis and hypertrophy: Molecular pathways, cellular mechanisms, and future directions

被引:62
作者
Sun, Chao [1 ]
Zhang, Han [1 ]
Wang, Xiang [1 ]
Liu, Xinhui [1 ]
机构
[1] Nanjing Med Univ, Affiliated Jiangning Hosp, Dept Spine Surg, Nanjing 211100, Peoples R China
基金
中国国家自然科学基金;
关键词
extracellular matrix; fibroblasts; fibrosis; ligamentum flavum; TGF-beta; 1; LUMBAR SPINAL STENOSIS; TISSUE GROWTH-FACTOR; FACET JOINT TISSUE; MATRIX METALLOPROTEINASES; INCREASED EXPRESSION; CONNECTIVE-TISSUE; CANAL STENOSIS; LYSOPHOSPHATIDIC ACID; TGF-BETA; EXTRACELLULAR-MATRIX;
D O I
10.1096/fj.202000635R
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Hypertrophy of ligamentum flavum (LF), along with disk protrusion and facet joints degeneration, is associated with the development of lumbar spinal canal stenosis (LSCS). Of note, LF hypertrophy is deemed as an important cause of LSCS. Histologically, fibrosis is proved to be the main pathology of LF hypertrophy. Despite the numerous studies explored the mechanisms of LF fibrosis at the molecular and cellular levels, the exact mechanism remains unknown. It is suggested that pathophysiologic stimuli such as mechanical stress, aging, obesity, and some diseases are the causative factors. Then, many cytokines and growth factors secreted by LF cells and its surrounding tissues play different roles in activating the fibrotic response. Here, we summarize the current status of detailed knowledge available regarding the causative factors, pathology, molecular and cellular mechanisms implicated in LF fibrosis and hypertrophy, also focusing on the possible avenues for anti-fibrotic strategies.
引用
收藏
页码:9854 / 9868
页数:15
相关论文
共 46 条
  • [41] Interplay between extracellular matrix components and cellular and molecular mechanisms in kidney fibrosis
    Rayego-Mateos, Sandra
    Campillo, Sofia
    Rodrigues-Diez, Raul R.
    Tejera-Munoz, Antonio
    Marquez-Exposito, Laura
    Goldschmeding, Roel
    Rodriguez-Puyol, Diego
    Calleros, Laura
    Ruiz-Ortega, Marta
    CLINICAL SCIENCE, 2021, 135 (16) : 1999 - 2029
  • [42] Diabetes-associated cardiac fibrosis: Cellular effectors, molecular mechanisms and therapeutic opportunities
    Russo, Ilaria
    Frangogiannis, Nikolaos G.
    JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2016, 90 : 84 - 93
  • [43] Cellular mechanisms and molecular signaling pathways in stress-induced anxiety, depression, and blood-brain barrier inflammation and leakage
    Welcome, Menizibeya O.
    INFLAMMOPHARMACOLOGY, 2020, 28 (03) : 643 - 665
  • [44] Systemic Sclerosis at the Cellular Level: Molecular Pathways of Pathogenesis and its Implication on Future Drug Design
    Schulz, S. W.
    Derk, C. T.
    CURRENT MEDICINAL CHEMISTRY, 2009, 16 (30) : 3986 - 3995
  • [45] From Inflammation to Fibrosis—Molecular and Cellular Mechanisms of Myocardial Tissue Remodelling and Perspectives on Differential Treatment Opportunities
    Suthahar N.
    Meijers W.C.
    Silljé H.H.W.
    de Boer R.A.
    Current Heart Failure Reports, 2017, 14 (4) : 235 - 250
  • [46] Cellular mechanisms and molecular pathways linking bitter taste receptor signalling to cardiac inflammation, oxidative stress, arrhythmia and contractile dysfunction in heart diseases
    Welcome, Menizibeya O.
    Dogo, Dilli
    Mastorakis, Nikos E.
    INFLAMMOPHARMACOLOGY, 2023, 31 (01) : 89 - 117